117 related articles for article (PubMed ID: 33905)
1. Inhibition of the interaction between the complement component Clq and immune complexes.
Allan R; Rodrick M; Knobel HR; Isliker H
Int Arch Allergy Appl Immunol; 1979; 58(2):140-8. PubMed ID: 33905
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.
Fletcher DS; Lin TY
J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441
[TBL] [Abstract][Full Text] [Related]
3. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
Gabriel A; Agnello V
J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
[TBL] [Abstract][Full Text] [Related]
4. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
Zubler RH; Lange G; Lambert PH; Miescher PA
J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
[TBL] [Abstract][Full Text] [Related]
5. The Clq receptor site on immunoglobulin G.
Burton DR; Boyd J; Brampton AD; Easterbrook-Smith SB; Emanuel EJ; Novotny J; Rademacher TW; van Schravendijk MR; Sternberg MJ; Dwek RA
Nature; 1980 Nov; 288(5789):338-44. PubMed ID: 6776418
[TBL] [Abstract][Full Text] [Related]
6. On the mechanism of Clq binding to antibody-I. aggregation and/or distortion of IgG vs combining site-transmitted effects.
Liberti PA; Bausch DM; Schoenberg LM
Mol Immunol; 1982 Jan; 19(1):143-9. PubMed ID: 6176855
[TBL] [Abstract][Full Text] [Related]
7. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
[TBL] [Abstract][Full Text] [Related]
8. Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.
Arima T; Narumoto J; Shimomura H; Suwaki K; Kunishi K; Yasuhara T; Nagashima H
Gastroenterol Jpn; 1980; 15(1):20-6. PubMed ID: 6153627
[TBL] [Abstract][Full Text] [Related]
9. Discrepancy between Clq deviation and Raji cell tests in detection of circulating immune complexes in patients with leprosy.
Tung KS; Kim B; Bjorvatn B; Kronvall G; McLaren LC; Williams RC
J Infect Dis; 1977 Aug; 136(2):216-21. PubMed ID: 330768
[TBL] [Abstract][Full Text] [Related]
10. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.
Lurhuma AZ; Cambiaso CL; Masson PL; Heremans JF
Clin Exp Immunol; 1976 Aug; 25(2):212-26. PubMed ID: 954232
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
12. Isolation of immune complexes by an equine Clq-like factor.
McDonald TL
Immunol Commun; 1981; 10(8):741-52. PubMed ID: 6176533
[TBL] [Abstract][Full Text] [Related]
13. Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.
Schumaker VN; Calcott MA; Spiegelberg HL; Müller-Eberhard HJ
Biochemistry; 1976 Nov; 15(23):5175-81. PubMed ID: 990273
[TBL] [Abstract][Full Text] [Related]
14. Detection of a high-affinity binding site for the globular head regions of the C1q complement protein on a human diploid fibroblast subtype.
Bordin S; Page RC
Mol Immunol; 1989 Jul; 26(7):677-85. PubMed ID: 2789337
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.
Collins MM; Casavant CH; Stites DP
J Clin Microbiol; 1982 Mar; 15(3):456-64. PubMed ID: 6804486
[TBL] [Abstract][Full Text] [Related]
16. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
Kohro-Kawata J; Wener MH; Mannik M
J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
[TBL] [Abstract][Full Text] [Related]
17. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
Van Dijk H; Van Voorst J; Jankowski IG; Imhof JW; Kerckhaert JA
Clin Exp Immunol; 1984 Aug; 57(2):495-501. PubMed ID: 6432386
[TBL] [Abstract][Full Text] [Related]
18. Binding and activation of the first complement component by soluble immune complexes: effect of complex size and composition.
Doekes G; van Es LA; Daha MR
Scand J Immunol; 1984 Feb; 19(2):99-110. PubMed ID: 6701474
[TBL] [Abstract][Full Text] [Related]
19. Activation of the classical and alternative pathways of complement fixation by immune complexes containing normal and tryptophan-modified immunoglobulin G.
Rodrick M; Allan R; Isliker H
J Immunol Methods; 1978; 22(3-4):211-8. PubMed ID: 567237
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.
Goers JW; Ziccardi RJ; Schumaker VN; Glovsky MM
J Immunol; 1977 Jun; 118(6):2182-91. PubMed ID: 559020
[No Abstract] [Full Text] [Related]
[Next] [New Search]
